Association of liver steatosis and fibrosis with clinical outcomes in patients with SARS-CoV-2 infection (COVID-19)
Ann Hepatol
.
2021 May-Jun:22:100295.
doi: 10.1016/j.aohep.2020.100295.
Epub 2020 Nov 27.
Author
Xiaofei Li
1
Affiliation
1
Department of Infectious Diseases, YiWu Central Hospital, Zhejiang 322000, China. Electronic address: icqwc46@163.com.
PMID:
33253894
PMCID:
PMC7694462
DOI:
10.1016/j.aohep.2020.100295
No abstract available
Publication types
Letter
Comment
MeSH terms
COVID-19*
Fatty Liver* / diagnosis
Fatty Liver* / epidemiology
Fibrosis
Humans
SARS-CoV-2